MRSN

Mersana Therapeutics (MRSN)

Mersana Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MRSN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	21:26	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/10	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/10	06:06	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/09	22:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/09	20:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/09	19:59	GlobeNewswire Inc.	Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/04	05:30	GlobeNewswire Inc.	Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/02	21:00	GlobeNewswire Inc.	Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/04/05	05:30	GlobeNewswire Inc.	Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/29	06:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/29	06:07	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/29	06:05	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/28	22:49	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/28	22:43	Edgar (US Regulatory)	Form POSASR - Post-effective Amendment to an automatic shelf registration statement	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/28	21:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/28	21:00	GlobeNewswire Inc.	Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/27	22:01	GlobeNewswire Inc.	Mersana Therapeutics to Present at Upcoming Investor Conferences	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/21	22:00	GlobeNewswire Inc.	Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/17	06:30	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/15	10:56	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/15	10:43	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/14	23:20	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/01	22:00	GlobeNewswire Inc.	Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc